Target intelligence / Profile preview

Cyclin L2 pseudogene 1 (CCNL2P1)

Target: CCNL2P1
Molecular classification: Other (pseudogene)

Overview

Cyclin L2 pseudogene 1 (CCNL2P1) is annotated as a pseudogene, meaning it resembles the functional cyclin L2 gene but is generally considered nonfunctional and does not produce a biologically active protein. Unlike functional cyclin genes, pseudogenes typically arise through gene duplication or retrotransposition events, and are not actively involved in cellular processes, drug targeting, or disease mechanisms. All currently described functions, disease associations, and molecular pathways relate to the active gene cyclin L2 (CCNL2), not to CCNL2P1[2][1].

Beyond the preview

Go deeper on Cyclin L2 pseudogene 1 (CCNL2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin L2 pseudogene 1 (CCNL2P1).

Explore the full profile